Healthpeak Properties, Inc. (NYSE:PEAK) Receives $36.94 Consensus Target Price from Analysts

Shares of Healthpeak Properties, Inc. (NYSE:PEAKGet Rating) have been given a consensus rating of “Hold” by the nine analysts that are covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and four have issued a buy rating on the company. The average 12 month price objective among analysts that have updated their coverage on the stock in the last year is $36.94.

Several equities research analysts have recently weighed in on the company. Morgan Stanley decreased their price objective on Healthpeak Properties from $35.50 to $34.50 and set an “equal weight” rating for the company in a report on Monday, March 7th. Credit Suisse Group increased their price objective on Healthpeak Properties from $37.00 to $38.00 and gave the company a “neutral” rating in a report on Monday, April 4th.

PEAK traded up $0.27 on Friday, reaching $30.08. The company’s stock had a trading volume of 3,576,684 shares, compared to its average volume of 3,252,806. The stock has a 50 day moving average of $33.44 and a two-hundred day moving average of $33.95. The company has a quick ratio of 0.87, a current ratio of 0.87 and a debt-to-equity ratio of 0.91. The company has a market capitalization of $16.23 billion, a price-to-earnings ratio of 38.08, a P/E/G ratio of 2.75 and a beta of 0.73. Healthpeak Properties has a fifty-two week low of $29.22 and a fifty-two week high of $37.69.

Healthpeak Properties (NYSE:PEAKGet Rating) last announced its quarterly earnings results on Tuesday, May 3rd. The company reported $0.13 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.42 by ($0.29). The business had revenue of $498.40 million during the quarter, compared to analyst estimates of $490.02 million. Healthpeak Properties had a net margin of 22.11% and a return on equity of 4.22%. The business’s revenue for the quarter was up 9.5% compared to the same quarter last year. During the same period last year, the company earned $0.40 earnings per share. As a group, analysts anticipate that Healthpeak Properties will post 1.73 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Friday, May 20th. Stockholders of record on Monday, May 9th will be paid a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 3.99%. The ex-dividend date of this dividend is Friday, May 6th. Healthpeak Properties’s dividend payout ratio (DPR) is presently 151.90%.

Several institutional investors have recently added to or reduced their stakes in PEAK. GHP Investment Advisors Inc. purchased a new stake in shares of Healthpeak Properties during the first quarter worth approximately $26,000. Cyrus J. Lawrence LLC purchased a new position in Healthpeak Properties in the first quarter worth $29,000. Nauset Wealth Management. LLC purchased a new position in Healthpeak Properties in the first quarter worth $29,000. Carl Stuart Investment Advisor Inc. purchased a new position in Healthpeak Properties in the first quarter worth $32,000. Finally, Certified Advisory Corp purchased a new position in Healthpeak Properties in the first quarter worth $33,000. Institutional investors and hedge funds own 95.98% of the company’s stock.

About Healthpeak Properties (Get Rating)

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns and develops high-quality real estate in the three private-pay healthcare asset classes of Life Science, Medical Office and Senior Housing, designed to provide stability through the inevitable industry cycles.

Recommended Stories

Analyst Recommendations for Healthpeak Properties (NYSE:PEAK)

Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.